comparemela.com

Latest Breaking News On - Pathalys pharma - Page 2 : comparemela.com

Emergent BioSolutions Names Two Pharmaceutical Industry Veterans to Board of Directors - Liquidia (NASDAQ:LQDA), Emergent BioSolutions (NYSE:EBS)

GAITHERSBURG, Md., Oct. 02, 2023 (GLOBE NEWSWIRE) Emergent BioSolutions Inc. (NYSE:EBS) today announced the appointment of Neal Fowler and Don DeGolyer to its Board of Directors effective October 1, 2023, with

United statesNeal fowlerEli lillyRichard lindahlZsolt harsanyiMcneil neurologicsDon degolyerMatt hartwigStrong women foundationMaster of business administrationEmergent biosolutions incExchange commissionUniversity of north carolina at chapel hillCommittee of sandozEndo internationalLiquidia corporation

Emergent BioSolutions Names Two Pharmaceutical Industry Veterans to Board of Directors

GAITHERSBURG, Md., Oct. 02, 2023 Emergent BioSolutions Inc. today announced the appointment of Neal Fowler and Don DeGolyer to its Board of Directors effective October 1, 2023, with initial.

United statesZsolt harsanyiMcneil neurologicsNeal fowlerMatt hartwigRichard lindahlEli lillyDon degolyerEndo internationalFairleigh dickinson universityEmergent biosolutions incPathalys pharma incExchange commissionUniversity of north carolina at chapel hillLiquidia corporation nasdaqEshelman school of pharmacy foundation

Private NCInnovation pushes lawmakers for $1 4B earmark in state budget

State budget negotiators are weighing $1.4 billion for NCInnovation, a private, non-profit aimed at providing grants to commercialize university or research.

United statesEast carolina universityNorth carolinaRick perryNeal fowlerDonald brysonBrian balfourStan kellyPathalys pharmaKelly kingJohn locke foundationResearch for the john locke foundationLife science centerPiedmont triad partnershipTexas emerging technology fundGolden leaf foundation

Senate budget boosts funding for commercializing university research

The Senate budget proposal allocates $1.425 billion to NCInnovation, a non-profit aimed at fostering innovation and economic growth in the state.

North carolinaUnited statesEast carolina universityPaul newtonNeal fowlerJamie dimonPeter hansKelly kingStan kellyPathalys pharmaResearch triangleWaste industriesCarolina senate republicansUniversity of north carolina at charlottePiedmont triad partnershipDuke energy

Biotech Financing Roundup: Belharra, NextPoint, Pathalys & More

Cancer continues to be a hot area of investment, and it’s the therapeutic focus of several biotech companies that have closed recent rounds of financing. Meanwhile, the investment arm of a big pharmaceutical company has an infusion of new cash to deploy in therapeutic and digital investments.

United statesUnited kingdomMenlo parkPathalys pharmaArix bioscienceScripps researchLangone healthCystic fibrosis foundationBelharra therapeuticsNorth carolina based pathalysRecode therapeuticsCalifornia based recodeAethon therapeuticsNew york basedCancer discoveryApple tree partners

vimarsana © 2020. All Rights Reserved.